REGN, XYZ, RTX, NVDA stock sentiment
🦉 Rise and shine. The market kept buzzing all day, and a handful of stocks owned the conversation.
How to read each name below: first line = how morningowl sentiment moved since yesterday, second = where it stands now (-100 to +100).
Develops and commercializes biologic medicines for eye diseases, cancer, and inflammatory conditions.
Each group's sentiment and how much it drove today's overall move:
News sentiment -49; led today's move, on unusually heavy chatter.
Retail sentiment -46; added to it.
News commentary centered on the competitive threat from Kodiak Sciences' Phase 3 readout, where Zenkuda and tabirafusp matched Eylea on macular degeneration endpoints at roughly six-month dosing versus Eylea's eight-week interval, alongside the shares slipping 4.54% to $752.25 despite a firm one-year return. Retail chatter zeroed in on the same Kodiak DAYBREAK data, flagging a planned Q4 BLA filing for Zenkuda across wet AMD and other indications and framing Eylea as facing obsolescence. Both groups converged on the eye-disease rivalry as the cautious driver, differing mainly in tone rather than direction.
As of 2026-09-28, Regeneron carried a P/E of 18.1, with its last close at the 36.5 percentile of its trailing three-month range and the 59.9 percentile of its 12-month range, down 6.9% over the past month. The company is scheduled to report earnings on 2026-10-30. As of 2026-09-01, coverage leaned favorable, with 26 favorable and 12 neutral opinions and none cautious across 38 analysts.
Provides payment processing, point-of-sale hardware, and financial tools for businesses and individuals.
Each group's sentiment and how much it drove today's overall move:
Retail sentiment -92; led today's move.
News sentiment +43; leaned against the move.
Retail commentary is downbeat, fixated on stagnant price action, chatter dwelling on the stock sitting near the same level as eight years ago and doubts it can clear and hold $80. News commentary strikes a favorable tone, centered on a Zacks Analyst Blog item on SoFi's stablecoin rollout that frames XYZ within a payments comparison against PayPal. The two diverge sharply: retail voices linger on long-term price frustration, while the news thread engages with sector positioning and valuation rather than the shares' recent slide.
As of September 28, 2026, Block Inc carried a P/E of 124.7, with its last close sitting near the bottom of its trailing three-month range, at the 1.6 percentile, and at the 59.5 percentile of its 12-month range, down 13.6% over the past month. Coverage leans favorable, with 43 favorable and 10 neutral views as of September 1, 2026. The company is scheduled to report earnings on November 4, 2026.
Supplies aerospace and defense systems, aircraft engines, and advanced sensors for commercial, military, and government customers.
Each group's sentiment and how much it drove today's overall move:
Retail sentiment +61; led today's move.
Analyst sentiment +73; added to it, on unusually heavy chatter.
News sentiment +66; added to it.
Retail commentary centered on the $20.7 billion Air Force AMRAAM contract, framing it as a broad missile-stockpile rebuild and citing a 250 price level. Analyst chatter, which came in unusually heavy, echoed the same AMRAAM award alongside a smaller $249.7M Collins Aerospace Navy contract, with one piece taking a favorable view of the earnings-yield pullback. News commentary focused squarely on the same AMRAAM deal, describing record-setting production under a five-year multi-year agreement. All three groups aligned on the contract as the driving catalyst, differing mainly in emphasis: retail on the upside runway, analysts adding the valuation angle and a second contract win, and news on the production-scale detail.
As of 2026-09-28, RTX Corp carries a P/E of 32.6, and its last close sat at the 1.6 percentile of its trailing three-month range and the 48.0 percentile of its twelve-month range, down 11.5% over the past month. The company is scheduled to report earnings on 2026-10-27. As of 2026-09-01, analyst coverage leans favorable, with 20 favorable, 9 neutral, and 1 cautious.
Designs GPUs and AI computing platforms for gaming, data centers, and autonomous vehicles.
Each group's sentiment and how much it drove today's overall move:
News sentiment +79; led today's move, on unusually heavy chatter.
Retail sentiment +57; added to it.
Analyst sentiment +55; added to it, on unusually heavy chatter.
News commentary centered on Nvidia's historic $150B share repurchase and buildout demand, from Musk's Colossus 2 plan for 1.44M chips to Anthropic's $518B infrastructure commitment, framing the buyback as a confidence signal. Retail echoed the favorable buyback read and cheered the stock's resilience, with one post flagging near-term call options at the 232.5/235 strikes as a short-term volume play. Analysts stayed favorable, highlighting Nvidia as a core AI infrastructure play alongside the Samsung-KKR-backed Helix investment and noting the stock closed at $228.86, up 1.68% on a down-market day, though some pointed to Broadcom's custom silicon as a competing AI opportunity. All three groups aligned on the buyback as the day's positive catalyst, differing mainly in emphasis, news on scale, retail on trade setups, analysts on where the next leg comes from.
As of 2026-09-28, NVIDIA carried a P/E of 29.0, with its last close at the 96.8 percentile of its trailing three-month range and the 98.8 percentile of its twelve-month range, up 0.5% over the past month. As of September 1, 2026, coverage leaned favorable across 69 analysts, with 65 favorable, 3 neutral, and 1 cautious. The company is scheduled to report earnings on 2026-11-17.
That's all four birds in the nest for today, go touch some grass and let the market do its thing. 🦉☕
This is not investment advice. morningowl is a publisher, not a registered investment adviser. We may hold positions in any security mentioned. Past performance and historical commentary patterns do not predict future results. Our data and analysis are provided "as is" and may contain inaccuracies; we accept no liability for errors or for any decisions made in reliance on them.
Important: please read
morningowl publishes information, not financial advice. Nothing we publish is a recommendation, solicitation, or offer to buy or sell any security, and nothing here should be taken as investment, legal, tax, or accounting advice. We are not a registered investment adviser, broker-dealer, or financial planner, and no content constitutes a fiduciary relationship of any kind. Our notes describe aggregated public commentary and may be incomplete, delayed, or wrong. Markets carry risk, including loss of principal. Always do your own research and consult a licensed professional before making any financial decision. You are solely responsible for your own decisions.